An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (20)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (2)
  • White paper (1)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (4)
  • Breast (1)
  • Gastro-intestinal (1)
  • Genito-urinary (0)
  • Gynecological (0)
  • Head and neck (10)
  • Hodgkin and Non-Hodgkin lymphoma (1)
  • Ocular (0)
  • Pediatric (1)
  • Reirradiation (0)
  • Sarcomas (0)
  • Thoracic (1)
  • Reset filters
  • (-) VMAT

Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study

19/02/2025
/ Publications
/
VMAT
Survival

Published in the Green Journal, this study from Taiwan compared treatment results of 276 patients with NPC treated with IMPT with a matched cohort of 276...

Intensity Modulated Proton Beam Therapy versus Volumetric Modulated Arc Therapy for Patients with Nasopharyngeal Cancer: A Propensity Score-Matched Study

08/07/2021
/ Publications
/
IMPT
VMAT

This study conducted a retrospective propensity score matching analysis (1:1) of 80 NPC patients treated with IMPT and VMAT. At a median follow-up time of 24.1...

Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer.

03/03/2020
/ Publications
/
IMPT
Chemotherapy
VMAT

This study compared 46 IMPT and 259 VMAT patients acute toxicities and reported that IMPT was associated with lower PEG-tube placement (p = 0.001) and less...

Comparing second cancer risk for multiple radiotherapy modalities in survivors of Hodgkin lymphoma

10/04/2021
/ Publications
/
Secondary cancer
VMAT

Using Excess Absolute Risk (EAR) models, this study compared the risk of secondary cancer for Hodgkin lymphoma survivors after either IMRT or PBT radiation...

The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation

10/12/2020
/ Publications
/
VMAT
IMPT

A cohort of 30 patients was retrospectively selected as "at-risk" of dose de-escalation due to the proximity of the target volumes to dose-limiting healthy...

Lower doses to hippocampi and other brain structures for skull-base meningiomas with IMPT compared to photon therapy.

07/09/2019
/ Publications
/
IMPT
VMAT

This study systematically compared intensity modulated proton therapy (IMPT), non-coplanar volumetric modulated arc therapy (VMAT) and intensity modulated...

Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy.

07/07/2019
/ Publications
/
VMAT

40 patients treated with PBT were selected for VMAT re-plan. The VMAT and delivered PT plans were compared by dose/volume metrics and NTCP models related to...

Comparison of supine or prone crawl photon or proton breast and regional lymph node radiation therapy including the internal mammary chain.

03/03/2019
/ Publications
/
VMAT
IMPT

A planning study conducted by a group of collective researchers in Europe. For six left sided breast cancer patients, treatment plans were made using non...

IMPT decreases dose to organs at risk in low-grade glioma patients

11/11/2018
/ Publications
/
IMRT
VMAT
IMPT

Patients with low-grade glioma (LGG) have a prolonged survival expectancy, therefore long-term side effects caused by radiotherapy is a concern. This...

Should we do ARC Therapy with Particles?

27/10/2021
/ Publications
/
VMAT
ARC therapy

Arc therapies such as VMAT are standard practice in photon radiation therapy due to, for instance, their dose shaping capabilities. Naturally, arc therapies do...

Pagination

    • Current page 1
    • Page 2
    • Page 3
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies